| CAS No. | 869486-05-5 |
| Molecular Formula | C42H33IrN6 |
| Molecular Weight | 813.97 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
The molecular framework of (OC-6-22)-Tris[(3-methyl-1H-benzimidazol-1-yl-2(3H)-ylidene)-1,2-phenylene]iridium (C42H33IrN6) is characterized by a nitrogen-containing heterocyclic scaffold, a nitrile group. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
(OC-6-22)-Tris[(3-methyl-1H-benzimidazol-1-yl-2(3H)-ylidene)-1,2-phenylene]iridium (CAS 869486-05-5) is a high-purity analytical reference standard with the molecular formula C42H33IrN6 and a molecular weight of 813.97 g/mol.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures (OC-6-22)-Tris[(3-methyl-1H-benzimidazol-1-yl-2(3H)-ylidene)-1,2-phenylene]iridium under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C42H33IrN6 |
| Molecular Weight | 813.97 g/mol |
| Purity | 97%+ |
| Storage | Store at room temperature, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 29.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1987 |
| Nitrogen Atoms | 6 |